{{'Search' | translate}}
 

Bio-SafeTM Coomassie Stain

Bio-Safe TM Coomassie Stain

Company: Bio-Rad Laboratories
Catalog#: 1610786
Bio-protocol()
Company-protocol()
Other protocol()

In vitro Analysis of Ubiquitin-like Protein Modification in Archaea
Author:
Date:
2018-05-20
[Abstract]  The ubiquitin-like (Ubl) protein is widely distributed in Archaea and involved in many cellular pathways. A well-established method to reconstitute archaeal Ubl protein conjugation in vitro is important to better understand the process of archaeal Ubl protein modification. This protocol describes the in vitro reconstitution of Ubl protein modification and following analysis of this modification in Haloferax volcanii, a halophilic archaeon serving as the model organism. [摘要]  泛素样(Ubl)蛋白广泛分布于古细菌中并参与许多细胞途径。 为了更好地理解古细菌Ub1蛋白质修饰的过程,重建体外古细菌Ubl蛋白质缀合物的完善方法是很重要的。 该协议描述了Ubl蛋白质修饰的体外重建以及在作为模型生物的嗜盐古细菌Haloferax volcanii 中对这种修饰进行分析。

【背景】泛素(Ub)与靶蛋白共价连接的过程被称为泛素化,其控制真核细胞中大量的细胞过程(Glickman和Ciechanover,2002; Komander和Rape,2012)。遍在蛋白化由一系列酶(包括Ub激活酶(E1),Ub结合酶(E2s)和Ub连接酶(E3s))催化。泛素化的体外重建是确定酶之间或E3与蛋白质底物之间特异性的有用测定法(Zhao等人,2012)。在古细菌中,Ubl蛋白SAMP采用Ub折叠,并且与E1样酶UbaA催化的蛋白靶标异肽连接[Maupin-Furlow,(2014)综述]。尽管E1同系物在古细菌中广泛存在,但基于一级序列比较,在大多数古细菌中未预测经典E2或E3酶。我们最近对Haloferax volcanii的研究表明甲硫氨酸亚砜还原酶A(MsrA)是Ubl蛋白质修饰(sampylation)与UbaA一起在体内温和的氧化条件下和< (体外)(fu="">

Heterologous Expression and Purification of the CRISPR-Cas12a/Cpf1 Protein
Author:
Date:
2018-05-05
[Abstract]  This protocol provides step by step instructions (Figure 1) for heterologous expression of Francisella novicida Cas12a (previously known as Cpf1) in Escherichia coli. It additionally includes a protocol for high-purity purification and briefly describes how activity assays can be performed. These protocols can also be used for purification of other Cas12a homologs and the purified proteins can be used for subsequent genome editing experiments.


Figure 1. Timeline of activities for the heterologous expression and purification of Francisella novicida Cas12a (FnCas12a) from Escherichia coli
[摘要]  该协议提供了分步说明(图1),用于在大肠杆菌中异源表达新西兰弗朗西斯菌弗朗西丝菌Cas12a(以前称为Cpf1)。 它还包括一个高纯度纯化方案,并简要介绍如何进行活性测定。 这些方案也可以用于其他Cas12a同系物的纯化,并且纯化的蛋白质可以用于随后的基因组编辑实验。

“”src
图1.从大肠杆菌 异源表达和纯化<弗朗西斯弗朗西丝菌 Cas12a(FnCas12a)的活动时间表

【背景】原核CRISPR-Cas免疫系统通过使用CRISPR RNA(crRNA)作为外源DNA或RNA的序列特异性靶向的指导来提供针对病毒和质粒的保护(van der Oost等人,2014; Marraffini ,2015)。 1类CRISPR-Cas系统(包含I型,III型和IV型)通常形成多亚基蛋白-cRNA效应复合物,而2类系统(包含II型,V型和VI型)依赖于单个crRNA-引导的效应物核酸酶用于目标干扰(Mohanraju et al。 2016年)。

...

Producing GST-Cbx7 Fusion Proteins from Escherichia coli
Author:
Date:
2017-06-20
[Abstract]  This protocol describes the production of GST-Cbx7 fusion proteins from E. coli, originally developed in the recent publication (Zhen et al., 2016). The pGEX-6P-1-GST plasmids encoding the Cbx7 variants were transformed into BL21 competent cells. The fusion protein production was induced by isopropyl-beta-D-thiogalactopyranoside and they were purified by Glutathione Sepharose 4B. This protocol can be adapted for the purification of other proteins. [摘要]  该方案描述了最近在最近的出版物(Zhen等,2016)中开发的大肠杆菌GST-Cbx7融合蛋白的生产。 将编码Cbx7变体的pGEX-6P-1-GST质粒转化到BL21感受态细胞中。 通过异丙基-β-D-硫代吡喃半乳糖苷诱导融合蛋白的产生,并用谷胱甘肽琼脂糖4B纯化。 该方案可以适用于其他蛋白质的纯化。
【背景】Polycomb组(PcG)蛋白通过调节高阶染色质结构调节基因表达(Kerppola,2009; Simon和Kingston,2013)。 PcG蛋白通常存在于两种主要复合物Polycomb镇压复合物(PRC)1和2(Kerppola,2009; Simon和Kingston,2013)中。 PRC2是甲基转移酶,其催化组蛋白H3(H3K27me2 / 3)上赖氨酸27的二甲基和三甲基化(Cao等,2002); PRC1是在赖氨酸119(H2AK119Ub)上单核苷酸组氨酸H2A的泛素连接酶(Wang等,2004)。哺乳动物PRC1复合物进一步分为典型和变体PRC1(Gao等,2012,Tavares等,2012)。规范PRC1由每个Ring1(Ring1A / Ring1B),Pcgf(Mel18 / Bmi1),Phc(Phc1 / 2/3)和Cbx(Cbx2 / 4/6/7/8)蛋白之一组成。 ...

Comments